GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Long-Term Debt

Akeso (AKESF) Long-Term Debt : $417.6 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Akeso Long-Term Debt?

Akeso's Long-Term Debt for the quarter that ended in Jun. 2024 was $417.6 Mil.

Akeso's quarterly Long-Term Debt increased from Jun. 2023 ($310.1 Mil) to Dec. 2023 ($361.0 Mil) and increased from Dec. 2023 ($361.0 Mil) to Jun. 2024 ($417.6 Mil).

Akeso's annual Long-Term Debt increased from Dec. 2021 ($126.2 Mil) to Dec. 2022 ($203.9 Mil) and increased from Dec. 2022 ($203.9 Mil) to Dec. 2023 ($361.0 Mil).

Akeso Long-Term Debt Historical Data

The historical data trend for Akeso's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akeso Long-Term Debt Chart

Akeso Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial 15.20 27.31 126.19 203.86 360.95

Akeso Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 168.36 203.86 310.10 360.95 417.62

Akeso  (OTCPK:AKESF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Akeso Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Akeso's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Akeso Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (OTCPK:AKESF) » Definitions » Long-Term Debt
Comparable Companies
HKSE:01177 HKSE:01801 HKSE:06990 HKSE:01548 HKSE:01877 HKSE:02269 HKSE:01530 HKSE:09969 HKSE:01952 HKSE:09995 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
09926:Hong Kong 4RY:Germany
Address
6 Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Website
https://www.akesobio.com
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in USA.